Sanofi Loses Injunction Bid In Generic Eloxatin Spat
A federal judge has again denied Sanofi-Aventis US LLC's request for a preliminary injunction against Fresenius Kabi Pharma Ltd., one of the last remaining defendants in the pharmaceutical giant's battle to...To view the full article, register now.
Already a subscriber? Click here to view full article